Oncology billing services where the units carry the revenue

Oncology billing services manage the highest-stakes drug claims in medicine: buy-and-bill J-codes where the unit definition, not the dose, sets the billed quantity, and a units error can misstate a claim by a factor of a hundred. Around the drugs sit the chemotherapy administration hierarchy (96413, 96415, 96417), NDC reporting requirements, treatment-plan prior authorization through pathways programs run by eviCore, Carelon, and OncoHealth, and the white bagging rules that decide whether the practice may bill the drug at all. Flexbone runs eligibility, authorization, units and NDC review, and denial work for oncology groups inside your EHR and billing system.

How does buy-and-bill drug billing work in oncology?

The practice purchases the drug, administers it, and bills the payer a J-code whose quantity is set by the HCPCS unit definition rather than the dose. Pembrolizumab (J9271) is defined as 1 mg per unit, so a 200 mg dose bills 200 units; a claim filed as 1 unit understates the charge by two hundred times, and the reverse error overbills into audit territory. That units-error class is mechanical and expensive, which makes it worth checking on every claim. Discarded drug from single-dose vials bills with modifier JW, and Medicare Part B requires the JZ modifier attesting no waste when there was none. Many payers, and Medicaid programs in particular, also require the 11-digit NDC of the actual vial. Flexbone reviews units, wastage modifiers, and NDC agreement pre-submission, and runs the benefits check before the practice buys the drug.

How is chemotherapy administration billed?

Each encounter allows one initial administration service, and the rest of the day hangs off it. Chemotherapy infusion bills 96413 for the first hour of the initial drug, 96415 for each additional hour of the same infusion, and 96417 for each additional sequential infusion of a different drug. The initial-service hierarchy ranks chemotherapy above therapeutic infusion and therapeutic infusion above hydration, so a visit that mixes all three still reports one initial code, chosen from the top of the hierarchy, with the rest as sequential or additional services. Claims that report two initials, or that bill hours the infusion record does not support, deny or draw review. Radiation oncology adds its own rhythm: weekly treatment management bills 77427 once per five fractions. Flexbone checks the hierarchy and the time math against the infusion record, and its denials management agents work what still comes back.

How do treatment-plan authorization and white bagging work?

Payers increasingly authorize the regimen, not the drug. Oncology pathways programs run by eviCore, Carelon, OncoHealth, and the plans themselves review the treatment plan against staging, biomarkers, and prior lines of therapy, and an approval binds the claim to that plan: a mid-course change of drug, dose, or schedule needs a new or amended authorization before the next cycle, or the infusion delivered is not covered. White bagging is the other gate. Some plans require the drug to ship from their specialty pharmacy instead of the practice's inventory, and on a white-bagged claim the practice bills only the administration, never the J-code, because it never owned the drug. Billing the drug anyway denies and can trigger recoupment. Flexbone determines the sourcing rule per plan and drug, submits the plan-level requests, and tracks changes. The infusion and oncology PA page covers the criteria.

How does Flexbone run oncology billing?

Flexbone deploys browser and voice agents across the oncology revenue cycle. Agents verify eligibility and run the benefits investigation before the first cycle, determine the sourcing rule and submit the treatment-plan authorization, review units, wastage modifiers, NDC agreement, and the administration hierarchy before claims file, and work the denial queue by CARC code inside your EHR and billing system. The patient-facing side, treatment-schedule adherence calls, infusion scheduling, and referral intake from community practices, is covered on the AI for oncology page. Results write back with an audit trail, and exceptions route to your billers with the context attached, so a units question surfaces before the claim files rather than after the recoupment letter.